Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease.

Rahman M, Greene T, Phillips RA, Agodoa LY, Bakris GL, Charleston J, Contreras G, Gabbai F, Hiremath L, Jamerson K, Kendrick C, Kusek JW, Lash JP, Lea J, Miller ER 3rd, Rostand S, Toto R, Wang X, Wright JT Jr, Appel LJ.

Hypertension. 2013 Jan;61(1):82-8. doi: 10.1161/HYPERTENSIONAHA.112.200477. Epub 2012 Nov 19.

2.

Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.

White WB, Lacourciere Y, Gana T, Pascual MG, Smith DH, Albert KS.

Am Heart J. 2004 Oct;148(4):628-34.

PMID:
15459593
3.
4.

Antihypertensive efficacy of night-time graded-release diltiazem versus morning amlodipine in African Americans.

Wright JT Jr, Sica DA, Gana TJ, Bohannon K, Pascual LG, Albert KS.

Am J Hypertens. 2004 Sep;17(9):734-42.

PMID:
15363813
5.

Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease.

Crespo JJ, Piñeiro L, Otero A, Castiñeira C, Ríos MT, Regueiro A, Mojón A, Lorenzo S, Ayala DE, Hermida RC; Hygia Project Investigators.

Chronobiol Int. 2013 Mar;30(1-2):159-75. doi: 10.3109/07420528.2012.701459. Epub 2012 Oct 25.

PMID:
23098134
6.

Targeting nocturnal hypertension in type 2 diabetes mellitus.

Rossen NB, Knudsen ST, Fleischer J, Hvas AM, Ebbehøj E, Poulsen PL, Hansen KW.

Hypertension. 2014 Nov;64(5):1080-7. doi: 10.1161/HYPERTENSIONAHA.114.03958. Epub 2014 Aug 4.

7.

Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension.

Glasser SP, Neutel JM, Gana TJ, Albert KS.

Am J Hypertens. 2003 Jan;16(1):51-8.

PMID:
12517683
8.

Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension.

Hermida RC, Ríos MT, Crespo JJ, Moyá A, Domínguez-Sardiña M, Otero A, Sánchez JJ, Mojón A, Fernández JR, Ayala DE; Hygia Project Investigators.

Chronobiol Int. 2013 Mar;30(1-2):192-206. doi: 10.3109/07420528.2012.701460. Epub 2012 Oct 25.

PMID:
23098160
9.

Bedtime administration of long-acting antihypertensive drugs restores normal nocturnal blood pressure fall in nondippers with essential hypertension.

Takeda A, Toda T, Fujii T, Matsui N.

Clin Exp Nephrol. 2009 Oct;13(5):467-72. doi: 10.1007/s10157-009-0184-4. Epub 2009 May 16.

PMID:
19449087
10.

Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.

Moyá A, Crespo JJ, Ayala DE, Ríos MT, Pousa L, Callejas PA, Salgado JL, Mojón A, Fernández JR, Hermida RC; Hygia Project Investigators.

Chronobiol Int. 2013 Mar;30(1-2):116-31. doi: 10.3109/07420528.2012.702587. Epub 2012 Oct 25.

PMID:
23181613
11.

Maintenance of blood-pressure-lowering effect following a missed dose of aliskiren, irbesartan or ramipril: results of a randomized, double-blind study.

Palatini P, Jung W, Shlyakhto E, Botha J, Bush C, Keefe DL.

J Hum Hypertens. 2010 Feb;24(2):93-103. doi: 10.1038/jhh.2009.38. Epub 2009 May 21.

PMID:
19458624
12.

Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.

Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, Laurino S, Mascia S, Conte G, De Nicola L.

Am J Kidney Dis. 2007 Dec;50(6):908-17.

PMID:
18037091
13.

Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.

Oigman W, Gomes MA, Pereira-Barretto AC, Póvoa R, Kohlmann O, Rocha JC, Nobre F.

Clin Ther. 2013 May;35(5):702-10. doi: 10.1016/j.clinthera.2013.03.015. Epub 2013 Apr 25.

PMID:
23623755
14.

Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.

Hermida RC, Ayala DE, Mojón A, Fontao MJ, Fernández JR.

Chronobiol Int. 2011 Aug;28(7):601-10. doi: 10.3109/07420528.2011.589935. Epub 2011 Aug 8.

PMID:
21823969
15.

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG; African American Study of Kidney Disease and Hypertension Study Group.

JAMA. 2002 Nov 20;288(19):2421-31. Erratum in: JAMA. 2006 Jun 21;295(23):2726.

PMID:
12435255
17.

Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate.

White WB, Mansoor GA, Pickering TG, Vidt DG, Hutchinson HG, Johnson RB, Noveck R.

Am J Hypertens. 1999 Aug;12(8 Pt 1):806-14.

PMID:
10480474
18.

An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.

Miranda RD, Mion D Jr, Rocha JC, Kohlmann O Jr, Gomes MA, Saraiva JF, Amodeo C, Filho BL.

Clin Ther. 2008 Sep;30(9):1618-28. doi: 10.1016/j.clinthera.2008.09.008.

PMID:
18840367
19.

Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing.

Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR.

Chronobiol Int. 2010 Jul;27(6):1287-303. doi: 10.3109/07420528.2010.489167.

PMID:
20653455
20.

Antihypertensive efficacy and tolerability of once-daily sustained-release diltiazem alone and in combination with ramipril in hypertension.

Tuteja R, Swarup D, Saxena GN, Bhandari S, Sharma P.

J Assoc Physicians India. 1999 Oct;47(10):962-5.

PMID:
10778687

Supplemental Content

Support Center